Patient characteristics
| UPN . | DX . | Disease status at transplantation . | Age, y, at transplantation . | Sex . | Antiretroviral therapy . | Prior chemotherapy/radiotherapy . |
|---|---|---|---|---|---|---|
| 202 | NHL | 2nd CR | 54 | M | nelfinavir, lamivudine, stavudine | CHOP |
| 203 | HD* | 2nd CR | 29 | M | indinavir, lamivudine, stavudine | CHOP, Ifos/VP16, ESHAP, 4500Gy |
| 204 | NHL | 1st PR | 52 | M | nelfinavir, lamivudine, stavudine | CHOP, ESHAP, 3600Gy |
| 208 | NHL | 1st CR | 41 | M | nevirapin, nelfinavir, stavudine | CHOP, ESHAP |
| 209 | HD | 1st REL | 46 | M | indinavir, lamivudine | BOSE, ABVD, ESHAP |
| 400 | NHL | 2nd CR | 11 | M | nelfinavir, nevirapin, lamivudine | POG 8617, POG 9517, POG 9317 |
| 405 | NHL | 2nd PR | 44 | M | efavirenz, lamivudine, stavudine | CHOP, ESHAP, Rituxan |
| 406 | NHL | 1st CR | 38 | M | indinavir, lamivudine, stavudine | CHOP |
| 407 | NHL | 3rd CR | 37 | F | ritonavir, saquinavir, nevirapin, stavudine | CHOP, Ifos/VP16, Rituxan, ESHAP |
| UPN . | DX . | Disease status at transplantation . | Age, y, at transplantation . | Sex . | Antiretroviral therapy . | Prior chemotherapy/radiotherapy . |
|---|---|---|---|---|---|---|
| 202 | NHL | 2nd CR | 54 | M | nelfinavir, lamivudine, stavudine | CHOP |
| 203 | HD* | 2nd CR | 29 | M | indinavir, lamivudine, stavudine | CHOP, Ifos/VP16, ESHAP, 4500Gy |
| 204 | NHL | 1st PR | 52 | M | nelfinavir, lamivudine, stavudine | CHOP, ESHAP, 3600Gy |
| 208 | NHL | 1st CR | 41 | M | nevirapin, nelfinavir, stavudine | CHOP, ESHAP |
| 209 | HD | 1st REL | 46 | M | indinavir, lamivudine | BOSE, ABVD, ESHAP |
| 400 | NHL | 2nd CR | 11 | M | nelfinavir, nevirapin, lamivudine | POG 8617, POG 9517, POG 9317 |
| 405 | NHL | 2nd PR | 44 | M | efavirenz, lamivudine, stavudine | CHOP, ESHAP, Rituxan |
| 406 | NHL | 1st CR | 38 | M | indinavir, lamivudine, stavudine | CHOP |
| 407 | NHL | 3rd CR | 37 | F | ritonavir, saquinavir, nevirapin, stavudine | CHOP, Ifos/VP16, Rituxan, ESHAP |
UPN indicates unique patient number; DX, diagnosis; NHL, non-Hodgkin lymphoma; CR, complete remission; CHOP, cyclophosphamide, adriamycin, vincristine, prednisone; Ifos, Ifosfamide; VP-16, etoposide; ESHAP, etoposide, cytarabine, cisplatinum, prednisone; REL, relapse; BOSE, bleomycin, oncovin, streptozocin, etoposide; ABVD, adriamycin, bleomycin, vincristine substituted for vinblastine, dacarbazine; POG 8617, cyclophosphamide, adriamycin, cytarabine; POG 9517, cyclophosphamide, adriamycin, methotrexate, cytarabine, ifosfamide, etoposide; and POG 9317, ifosfamide, etoposide, methotrexate, cytarabine.
Initially dx NHL then changed to HD (Hodgkin disease).